DECREASED ALBUMINURIA BY PRAVASTATIN IN HYPERLIPIDEMIC DIABETICS

被引:43
作者
SHOJI, T
NISHIZAWA, Y
TOYOKAWA, A
KAWAGISHI, T
OKUNO, Y
MORII, H
机构
来源
NEPHRON | 1991年 / 59卷 / 04期
关键词
D O I
10.1159/000186665
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:664 / 665
页数:2
相关论文
共 9 条
  • [1] DULLAART RPF, 1989, DIABETOLOGIA, V32, P685
  • [2] FELDTRASMUSSEN B, 1986, LANCET, V2, P1300
  • [3] KEVIN PG, 1990, AM J KIDNEY DIS, V15, P16
  • [4] MOGENSEN CE, 1985, HYPERTENSION, V7, P64
  • [5] MORGENSEN CE, 1984, NEW ENGL J MED, V310, P356
  • [6] PARTIAL REMISSION OF NEPHROTIC SYNDROME IN PATIENT ON LONG-TERM SIMVASTATIN
    RABELINK, AJ
    HENE, RJ
    ERKELENS, DW
    JOLES, JA
    KOOMANS, HA
    [J]. LANCET, 1990, 335 (8696) : 1045 - 1046
  • [7] RECEPTOR-MEDIATED ENDOCYTOSIS OF LOW-DENSITY-LIPOPROTEIN BY CULTURED HUMAN GLOMERULAR CELLS
    RAYNER, HC
    HORSBURGH, T
    BROWN, SL
    LAVENDER, FL
    WINDER, AF
    WALLS, J
    [J]. NEPHRON, 1990, 55 (03): : 292 - 299
  • [8] ENALAPRIL REDUCES MICROALBUMINURIA IN YOUNG NORMOTENSIVE TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS IRRESPECTIVE OF ITS HYPOTENSIVE EFFECT
    RUDBERG, S
    APERIA, A
    FREYSCHUSS, U
    PERSSON, B
    [J]. DIABETOLOGIA, 1990, 33 (08) : 470 - 476
  • [9] VEBERTI GC, 1982, LANCET, V1, P1430